The Blue Cross Blue Shield of Michigan Cardiovascular Consortium, or BMC2, is a prospective, multicenter, collaborative effort to assess and improve quality of care and outcomes for patients with coronary disease. The initiative is made up of three registries:

  • Percutaneous Coronary Intervention – commonly known as angioplasty. This project looks at improving outcomes for patients undergoing coronary angioplasty.
  • Vascular Surgery – This project assesses quality of care and outcomes of patients with peripheral vascular disease who are undergoing open abdominal aneurysm repair, endovascular abdominal aneurysm repair and open bypass procedures of upper and lower extremities. The project also collects data on carotid artery procedures including carotid artery stenting and carotid endarterectomy.
  • TAVR (Transcatheter Aortic Valve Replacement) – This quality improvement project is designed to improve quality of care and outcomes in patients who undergo a percutaneous valve replacement procedure.

For more information, go to


The Blue Cross Blue Shield of Michigan Cardiovascular Consortium-Percutaneous Coronary Intervention (BMC2-PCI) was the first Collaborative Quality Initiative.  Results to date include:

  • PCI
    • 10.5% reduction in CIN (2008 – 2015)
    • 41.3% reduction in blood transfusions post-procedure (2008 – 2015)
    • 48.1% reduction in vascular access complications (2008 – 2015)
    • 15.4% increase in cardiac rehabilitation referral (2010 – 2015)
    • 7% reduction in total number of procedures (2010 – 2015)
    • 15.4% increase in use of pre-procedure Aspirin (2013 – 2015)
  • Vascular Surgery
    • 24.7% reduction in surgical site infection in non-emergent cases (2014 – 2015)
    • 26.4% increase in use of Chlorhexidine & alcohol skin preparation (2012 – 2015)
    • 21.9% increase in prescription of Any-Antiplatelet at discharge (2012 – 2015)
    • 18.3% increase in prescription of Statins prescribed at discharge (2012 – 2015)
    • 21.1% reduction in transfusions when asymptomatic with HgB ≥ 8 (2014 – 2015)
    • 57.7% increase in pre-procedure hydration for high-risk EVAR patients (2012 – 2015)
  •  TAVR
    • Created an agreed upon list of Incremental Risk percentages to add to the risk scores for TAVR
    • Distributed Clinical Pathways (Best Practices) for Femoral, Transaortic, and Transapical procedures
    • Developed quarterly and year-to-date base reports and 30-day and 1-year follow-up reports

Hospitals listed below participate in the PCI initiative. Vascular surgery and TAVR participants are subsets of these sites.


Participating Hospitals

Allegiance Health
Beaumont Hospital, Dearborn
Beaumont Hospital, Royal Oak
Beaumont Hospital, Troy
Borgess Medical Center
Bronson Methodist Hospital
Covenant Medical Center
Crittenton Hospital Medical Center
Genesys Regional Medical Center
Harper University Hospital & Hutzel’s Women’s Hospital
Henry Ford Hospital (Detroit)
Henry Ford Macomb Hospital – Clinton Township
Lakeland Hospitals at Niles & St.Joseph
McLaren Bay
McLaren Flint
McLaren Greater Lansing
McLaren Macomb
McLaren Northern Michigan Hospital
McLaren Port Huron Hospital
Mercy Health Partners – Muskegon
Michigan Medicine
MidMichigan Medical Center – Midland
Munson Medical Center
St. John Hospital and Medical Center
St. John Macomb Oakland
St. John Providence Hospital
St. Joseph Mercy Hospital Ann Arbor
St. Joseph Mercy Oakland
St. Mary’s of Michigan
Sinai-Grace Hospital
Sparrow Hospital
Spectrum Health
UP Health System Marquette